JP2022541634A5 - - Google Patents

Info

Publication number
JP2022541634A5
JP2022541634A5 JP2022504546A JP2022504546A JP2022541634A5 JP 2022541634 A5 JP2022541634 A5 JP 2022541634A5 JP 2022504546 A JP2022504546 A JP 2022504546A JP 2022504546 A JP2022504546 A JP 2022504546A JP 2022541634 A5 JP2022541634 A5 JP 2022541634A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
fmsd
composition according
sleep
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022504546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541634A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/043047 external-priority patent/WO2021016338A1/en
Publication of JP2022541634A publication Critical patent/JP2022541634A/ja
Publication of JP2022541634A5 publication Critical patent/JP2022541634A5/ja
Pending legal-status Critical Current

Links

JP2022504546A 2019-07-23 2020-07-22 疼痛に関連する睡眠障害を治療する方法 Pending JP2022541634A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962877573P 2019-07-23 2019-07-23
US62/877,573 2019-07-23
PCT/US2020/043047 WO2021016338A1 (en) 2019-07-23 2020-07-22 Methods of treating sleep disorders associated with pain

Publications (2)

Publication Number Publication Date
JP2022541634A JP2022541634A (ja) 2022-09-26
JP2022541634A5 true JP2022541634A5 (https=) 2023-07-28

Family

ID=72047043

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504546A Pending JP2022541634A (ja) 2019-07-23 2020-07-22 疼痛に関連する睡眠障害を治療する方法

Country Status (10)

Country Link
US (1) US20220370468A1 (https=)
EP (1) EP4003357A1 (https=)
JP (1) JP2022541634A (https=)
KR (1) KR20220038344A (https=)
CN (1) CN114144183A (https=)
AU (1) AU2020318996A1 (https=)
BR (1) BR112022001056A2 (https=)
CA (1) CA3147752A1 (https=)
MX (1) MX2022000892A (https=)
WO (1) WO2021016338A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320637D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
MX350745B (es) * 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
SG11201509989VA (en) * 2013-06-06 2016-01-28 Astellas Pharma Inc Benzothiophene compound

Similar Documents

Publication Publication Date Title
Foltynie et al. Medical, surgical, and physical treatments for Parkinson's disease
US11730706B1 (en) Treatment of depression in certain patient populations
US8946300B2 (en) Use of rasagilline for the treatment of restless legs syndrome
JP6406713B2 (ja) 低用量薬剤によるうつ病および他の疾患の処置
JP7548669B2 (ja) 炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物
CN103347495A (zh) 治疗帕金森病的阿片样激动剂与阿片样拮抗剂的组合
AU2010211491B2 (en) Medical use of 5-benzylaminosalicylic acid derivative or its salt
WO2013063263A1 (en) Pharmaceutical compositions for treating pain
JP2017531021A (ja) 多発性硬化症治療用のシポニモドとラキニモドを含む組み合わせ
US20240074993A1 (en) Methods of treating or preventing an attention disorder, cognitive disorder, and/or dementia associated with a neurodegenerative disorder
CN113710319B (zh) 用于治疗焦虑相关病症的组合物和方法
CN101801361A (zh) 抑郁症的治疗
TW202228666A (zh) 使用ghb之治療方法
JP2022541634A5 (https=)
Roth Narcolepsy: treatment issues
CN114028396B (zh) 汉防己甲素在用于制备治疗纤维肌痛的药物中的应用
JP2021530568A5 (https=)
US20160022659A1 (en) Methods for treating attention deficit hyperactivity disorder using a combination of bupropion ((±)-2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one) and phentermine (2-methyl-1-phenylpropan-2-amine)
JP2021513977A (ja) レストレスレッグズ症候群を治療するための治療薬
CN1447693A (zh) 血管紧张素ii拮抗剂的新用途
TW200911225A (en) Methods for improving physical function in fibromyalgia
RU2022104293A (ru) Способы лечения нарушений сна, связанных с болью
JP2022541634A (ja) 疼痛に関連する睡眠障害を治療する方法
CN1671368A (zh) 疼痛继发性抑郁(dsp)的治疗
TWI599371B (zh) 醫藥組合物用於製備治療檳榔使用失調之藥物上的用途